...
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer
【24h】

Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer

机译:5-氨基乙酰丙酸的临床诊断临床缺乏术治疗非血液侵袭性膀胱癌的临床益处中的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: This study was undertaken to evaluate the clinical value of photodynamic diagnosis (PDD) with intravesical and oral instillation of 5-aminolevulinic acid (ALA) (ALA-PDD), and transurethral resection of bladder tumor (TURBT) guided by ALA-PDD (PDD-TURBT) for nonmuscle invasive bladder cancer. Methods: Of all 210 cases, 75 underwent PDD with intravesically applied ALA, and 135 cases underwent PDD with orally applied ALA. Diagnostic accuracy was evaluated by comparing the level on images of ALA-induced fluorescence with the pathological result. PDD-TURBT was performed in 99 completely resectable cases corresponding to 210 ALA-PDD cases. To evaluate the abilities of PDD-TURBT, survival analysis regarding intravesical recurrence was retrospectively compared with the historical control cases that underwent conventional TURBT. Results: The diagnostic accuracy and capability of ALA-PDD were significantly superior to those of conventional endoscopic examination. Moreover, 72.1% of flat lesions, including dysplasia and carcinoma in situ, could be detected only by ALA-PDD. The recurrence-free survival rate in the cases that underwent PDD-TURBT was significantly higher than that of conventional TURBT. Moreover, multivariate analysis revealed that the only independent factor contributing to improving prognosis was PDD-TURBT (hazard ratio, 0.578; P =.012). Regardless of the ALA administration route, there was no significant difference in diagnostic accuracy, ability of PDD, or recurrence-free survival. All procedures were well tolerated by all patients without any severe adverse events. Conclusions: This multicenter study is likely to be biased, because it is limited by the retrospective analysis. This study suggests that regardless of the ALA administration route, ALA-PDD and PDD-TURBT are remarkably helpful in detection and intraoperative navigation programs.
机译:背景:本研究进行了评价光动力诊断(PDD)与5-氨基乙酰丙烯酸(ALA)(ALA-PDD)的膀胱内滴注(ALA-PDD)的临床价值,以及由ALA-PDD引导的膀胱肿瘤(TURBT)的经尿道切除(PDD-TURBT)用于非血液侵入性膀胱癌。方法:在所有210例患者中,75例接受PDD与膀胱型ALA,135例接受PDD的口服ALA。通过将ALA诱导的荧光图像与病理结果进行比较来评估诊断准确度。 PDD-TurBT在99例完全可重置案件中进行,对应于210 Ala-PDD病例。为了评估PDD-TURBT的能力,与经过常规TARBT的历史对照病例进行了回顾性地进行了关于膀胱内复发的存活分析。结果:ALA-PDD的诊断准确性和能力显着优于常规内窥镜检查。此外,仅通过ALA-PDD检测了72.1%的扁平病变,包括发育不良和癌症,也可以检测到癌症和癌。接受PDD-TurBT的案例中的可复发存活率明显高于传统的TurBT。此外,多变量分析显示,唯一有助于改善预后的独立因素是PDD-TYBT(危险比,0.578; p = .012)。无论ALA给药路线如何,诊断准确性没有显着差异,PDD的能力或无复发存活率。所有患者的所有程序都受到任何严重不良事件的所有患者都是良好的耐受性。结论:这种多中心的研究很可能被偏见,因为它受到回顾性分析的限制。本研究表明,无论ALA管理路线如何,ALA-PDD和PDD-TYB在检测和术中导航计划中都非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号